On the importance of the interplay of residual renal function with clinical outcomes in end-stage kidney disease.
Journal of nephrology
washington; spokane; pmrc; Humans; Quality of Life; Kidney Failure, Chronic; Peritoneal Dialysis; Renal Dialysis; Disease Progression; Kidney
Chronic kidney disease (CKD) is one of the most important public health concerns of the century, and is associated with high rates of morbidity, mortality and social costs. CKD evolving towards end-stage kidney disease (ESKD) is on the rise resulting in a greater number of patients requiring peritoneal dialysis (PD) and hemodialysis (HD). The aim of this manuscript is to review the current literature on the interplay of residual renal function (RRF) with clinical outcomes in ESKD. The persistence of RRF is one of the most important predictors of decreased morbidity, mortality, and better quality of life in both PD and HD patients. RRF contributes to the well-being of ESKD patients through various mechanisms including higher clearance of solutes, maintenance of fluid balance, removal of uremic toxins and control of electrolytes. Furthermore, RRF has beneficial effects on inflammation, anemia, malnutrition, diabetes mellitus, obesity, changes in the microbiota, and cardiac diseases. Several strategies have been proposed to preserve RRF, such as blockade of the renin-angiotensin-aldosterone system, better blood pressure control, incremental PD and HD. Several clinical trials investigating the issue of preservation of RRF are ongoing. They are needed to broaden our understanding of the interplay of RRF with clinical outcomes in ESKD.
Kidney & Diabetes
Tanriover, Cem; Ucku, Duygu; Basile, Carlo; Tuttle, Katherine; and Kanbay, Mehmet, "On the importance of the interplay of residual renal function with clinical outcomes in end-stage kidney disease." (2022). Articles, Abstracts, and Reports. 6828.